Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

CONTEXT: For patients with metastatic papillary thyroid carcinoma (PTC) refractory to radioactive iodine (RAI) treatment, systemic chemotherapy has limited efficacy. Such tumors frequently harbor BRAF V600E, and this alteration may predict responsiveness to vemurafenib treatment. OBJECTIVE: We repor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2014
Assuntos:
Published online: May, 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067722/
https://ncbi.nlm.nih.gov/pubmed/24987354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000363377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados